This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Endo International Dividend
Dividend criteriumcontroles 0/6
Endo International does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
n/a
Uitbetalingsratio
Gemiddelde opbrengst industrie | 2.2% |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Winst per aandeel | -US$10.41 |
Dividendrendementsvoorspelling | 0% |
Recente dividendupdates
Geen updates
Recent updates
Endo creditors looking at putting company up for sale through bankruptcy - Bloomberg
Aug 16Endo International sees 23% rise on 3x higher than normal volume
Aug 03Endo outperforms defying bankruptcy fears and generic entry
Jul 25Endo weighs bankruptcy filing without opioid settlement - WSJ
Jul 12Endo International cools off, giving back some of its 85% Tuesday gain
Jun 29Endo: Stick A Fork In It
May 10Endo: About As Bad As It Gets
Mar 07Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year
Dec 16Endo: A Win In California But Equity Value Still A Question
Nov 02Endo International: Loses Vasostrict Trial
Aug 31Endo International: Hires Restructuring Advisor
Aug 20Endo International: All About Ongoing Litigation
Aug 07Endo: Appellate Court Denies Request To Postpone Damages Trial Might Be End O' The Road
Jul 15Endo International: Bankruptcy Seems Like The Only Practical Option
Jun 30Endo International wins FDA approval for Micafungin new formulation
Jun 17Endo International plc 2021 Q1 - Results - Earnings Call Presentation
May 07Radius Health partners with Endo unit for abaloparatide in Canada
Jan 05Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if ENDP.Q's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if ENDP.Q's dividend payments have been increasing.
Dividendrendement versus markt
Endo International Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (ENDP.Q) | n/a |
Markt onderkant 25% (US) | 1.4% |
Markt Top 25% (US) | 4.3% |
Gemiddelde industrie (Pharmaceuticals) | 2.2% |
Analist prognose (ENDP.Q) (tot 3 jaar) | 0% |
Opmerkelijk dividend: Unable to evaluate ENDP.Q's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate ENDP.Q's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate ENDP.Q's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as ENDP.Q has not reported any payouts.